This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Vivian Xie
5 Dec 2022

Trend Report: The True Cost of API Price Rises

Download our Trend Report to discover what the current landscape of APIs and their pricing means for the pharmaceutical industry in the future.

Our latest Trend Report uncovers the true cost of rising API prices for all players in the pharmaceutical industry. We explore the effects of global supply chain disruptions, dependency issues on certain countries, and analyse the results of our API Trend Report survey asking the CPHI Online community for their insight. 

APIs are the substances within a pharmaceutical drug or therapeutic that provides the main source of beneficial health effects labelled by the drug. As global events continue to shape the pharmaceutical landscape, various reports predict an increase in API prices over the coming years.  

Through in-depth interviews with several experts in the API field and a public opinion survey, this CPHI Online Trend Report seeks to highlight how current API manufacturing and supply chain practices have led the industry to the pricing challenges it now faces, and illustrates strategies all pharmaceutical players can take to overcome these issues. 

Overcoming obstacles at CPHI Barcelona

The pharma industry is facing challenges across the board – only one of which is increasing costs. At CPHI Barcelona, find out how industry professionals are facing the future. Hear from – and meet – everyone from the big players to disruptive start-ups.

Your CPHI Barcelona pass gives you access to all conference sessions, including Formulating the Future, as well as the chance to connect in-person with the global pharma supply chain from 24-26 October, at Fira Barcelona Gran Via. Browse the agenda and secure your pass today!

Learn more

Mentioned Companies
View company profile
Vivian Xie
Editor - Custom Content

Related News